キッズバイオ announced after the market closed on the 18th that it would sell part of its listed securities holdings and record a gain of ¥221.717 million on the sale of investment securities. The sale period is from 1 to 18 September 2026, with the sale intended to strengthen its financial position and improve asset efficiency.
キッズバイオ disclosed that it had sold part of its listed securities holdings in response to share price movements. As a result, it expects to record a ¥221.717 million gain on the sale of investment securities.
The sale period is from 1 to 18 September 2026, and the sale is intended to strengthen its financial position and improve asset efficiency.
The gain on sale is scheduled to be recorded as extraordinary income in the second quarter of the fiscal year ending March 2027. The company said it would promptly disclose any necessary revision to its earnings forecasts in light of future developments.